The U.S. Federal Trade Commission won a ruling on Friday blocking Edwards Lifesciences’ acquisition of JenaValve Technology, court records showed.
The FTC sued in August, saying the deal would decrease competition in the market for a device meant to treat a potentially fatal heart condition.
Sign up here.
“This is a major win for the Trump-Vance administration,” said FTC spokesperson Joe Simons… [1319 chars]
Source: Reuters | Published: 2026-01-09T21:17:40Z
Credit: Reuters












